On the other hand, deletions and mutations in TP53 and NOTCH1 genes are frequently detected in patients with the most common in Russia subgroup CLL#1—16–30% [13,20,21]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.